비경구 조제 시장 규모, 점유율, 성장 분석 : 제품 유형별, 조제 유형별, 최종사용자별, 치료 영역별, 유통 채널별, 지역별 - 산업 예측(2026-2033년)

Global Parenteral Compounding Market size was valued at USD 14.76 Billion in 2024 and is poised to grow from USD 15.88 Billion in 2025 to USD 28.54 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global parenteral compounding market is pivotal for tailoring injectable medications in sterile settings, addressing patient-specific requirements such as dosage modifications and unique formulations. Its growth stems from a rising demand for personalized medicine, prompting hospitals and specialty pharmacies to produce biologics and high-potency drugs under stringent safety standards. Recent advancements in AI-driven automation enhance both safety and efficiency by integrating machine learning with robotic systems to ensure sterility, verify dosages, and monitor inventory in real time. This reduces the risk of human error and expedites preparation, enabling quicker access to patient-specific therapies. Moreover, technologies like robotic compounding lines improve operational efficiency, allowing healthcare providers to view compounding as a strategic revenue source, fostering opportunities for outsourcing and international collaborations.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Parenteral Compounding market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Parenteral Compounding Market Segments Analysis

Global parenteral compounding market is segmented by product type, compounding type, end user, therapeutic area, distribution channel and region. Based on product type, the market is segmented into Chemotherapy Preparations, Total Parenteral Nutrition, Sterile Injectable Preparations and Pain Management Preparations. Based on compounding type, the market is segmented into Patient-Specific Compounding and Batch Compounding. Based on end user, the market is segmented into Hospitals, Specialty Pharmacies and Ambulatory Infusion Centers. Based on therapeutic area, the market is segmented into Oncology, Critical Care, Infectious Diseases and Nutrition Support. Based on distribution channel, the market is segmented into In-House Pharmacy and Outsourced Compounding Services. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Parenteral Compounding Market

The Global Parenteral Compounding market is experiencing growth driven by the rising preference of healthcare providers for personalized intravenous therapies tailored to individual patient needs. This trend has led pharmacies to enhance their sterile compounding capabilities, prompting investments in advanced aseptic technologies and skilled personnel. The customization of dosage forms not only improves therapeutic outcomes but also builds trust among both clinicians and patients. As a result, the demand for high-quality compounding services is increasing, as healthcare institutions actively seek reliable partners who can offer personalized sterile products. Additionally, the adoption of electronic prescribing systems enhances traceability and compliance, further boosting provider confidence in compounded medicinal solutions.

Restraints in the Global Parenteral Compounding Market

The Global Parenteral Compounding market faces significant challenges due to the intricate web of national and international regulations governing sterility testing, facility design, and documentation requirements. Compliance with these stringent standards typically requires considerable investment in cleanroom construction, validation, and continuous staff training. The lengthy approval processes and regular audits can hinder product launches and elevate operational expenses, making it difficult for smaller companies to enter the market. As a result, the increased regulatory demands create obstacles that not only slow market growth but also narrow the range of qualified service providers, limiting overall competitiveness in the sector.

Market Trends of the Global Parenteral Compounding Market

The Global Parenteral Compounding market is experiencing a significant shift towards precision automation, as pharmacies and hospital pharmacies increasingly implement advanced robotic compounding systems. These systems enhance sterile preparation processes by minimizing human error and improving throughput, leading to greater operational efficiency. The incorporation of real-time analytics and closed-loop verification mechanisms allows for continuous monitoring of aseptic conditions, ensuring safety and quality. Additionally, modular designs facilitate customization for a variety of therapeutic formulations. This trend not only boosts product consistency but also enables skilled technicians to concentrate on complex clinical decision-making, effectively addressing the rising demand for personalized injectable therapies in a safe and reliable manner.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Parenteral Compounding Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Chemotherapy Preparations
• Total Parenteral Nutrition
• Sterile Injectable Preparations
• Pain Management Preparations

Global Parenteral Compounding Market Size by Compounding Type & CAGR (2026-2033)

• Market Overview
• Patient-Specific Compounding
• Batch Compounding

Global Parenteral Compounding Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Specialty Pharmacies
• Ambulatory Infusion Centers

Global Parenteral Compounding Market Size by Therapeutic Area & CAGR (2026-2033)

• Market Overview
• Oncology
• Critical Care
• Infectious Diseases
• Nutrition Support

Global Parenteral Compounding Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• In-House Pharmacy
• Outsourced Compounding Services

Global Parenteral Compounding Market Size & CAGR (2026-2033)

• North America (Product Type, Compounding Type, End User, Therapeutic Area, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Compounding Type, End User, Therapeutic Area, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Compounding Type, End User, Therapeutic Area, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Compounding Type, End User, Therapeutic Area, Distribution Channel)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Compounding Type, End User, Therapeutic Area, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Baxter International Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omnicell, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARxIUM Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capsa Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equashield LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Simplivia Healthcare Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Weinmann Emergency Medical Technology GmbH + Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer CentreOne
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fagron N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PCI Pharma Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• West Pharmaceutical Services, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medisca Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations